Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait

• Asıl Yazarlar: Ahmad Suhail (Yazar), Jaber Al-Anoud (Yazar), Mokaddas Eiman (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2009-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Ethambutol (EMB) is a first-line drug for the treatment of tuberculosis (TB). Resistance to EMB in <it>Mycobacterium tuberculosis </it>isolates is mediated by mutations in several genes involved in arabinan synthesis nota...